111 related articles for article (PubMed ID: 10455376)
21. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
22. [Autoimmune thrombocytopenia following syngeneic peripheral blood stem cell transplantation].
Nishio M; Sawada K; Koizumi K; Endoh T; Takashima H; Hashimoto H; Haseyama Y; Katagiri E; Fukada Y; Takano H; Tarumi T; Yasukouchi T; Koike T
Rinsho Ketsueki; 1998 Aug; 39(8):580-5. PubMed ID: 9785976
[TBL] [Abstract][Full Text] [Related]
23. Treatment intensification which includes high-dose induction improves survival of lung carcinoma patients treated by high-dose chemotherapy with hematopoietic progenitor cell rescue but does not prevent high rate of relapses.
Tomeczko J; Pacuszko T; Napora P; Lange A
Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S44-7. PubMed ID: 8899171
[No Abstract] [Full Text] [Related]
24. [Is there progress in the chemotherapy of small cell lung cancer?].
Calderoni A; Cerny T; Betticher DC
Schweiz Med Wochenschr; 1999 Sep; 129(37):1313-20. PubMed ID: 10515004
[TBL] [Abstract][Full Text] [Related]
25. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y
Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358
[TBL] [Abstract][Full Text] [Related]
26. Flt3 ligand and thrombopoietin serum levels during peripheral blood stem cell mobilization with chemotherapy and recombinant human glycosylated granulocyte colony-stimulating factor (rhu-G-CSF, lenograstim) and after high-dose chemotherapy.
Bojko P; Pawloski D; Stellberg W; Schröder JK; Seeber S
Ann Hematol; 2002 Sep; 81(9):522-8. PubMed ID: 12373354
[TBL] [Abstract][Full Text] [Related]
27. Randomized phase III trial of dose-dense chemotherapy supported by whole-blood hematopoietic progenitors in better-prognosis small-cell lung cancer.
Lorigan P; Woll PJ; O'Brien ME; Ashcroft LF; Sampson MR; Thatcher N
J Natl Cancer Inst; 2005 May; 97(9):666-74. PubMed ID: 15870437
[TBL] [Abstract][Full Text] [Related]
28. Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer.
Wong R; Rondon G; Saliba RM; Shannon VR; Giralt SA; Champlin RE; Ueno NT
Bone Marrow Transplant; 2003 Jun; 31(12):1157-63. PubMed ID: 12796796
[TBL] [Abstract][Full Text] [Related]
29. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
Weaver CH; Schulman KA; Buckner CD
Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
[TBL] [Abstract][Full Text] [Related]
30. High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II study.
Toh HC; McAfee SL; Sackstein R; Multani P; Cox BF; Garcia-Carbonero R; Colby C; Spitzer TR
Bone Marrow Transplant; 2000 Jan; 25(1):19-24. PubMed ID: 10654009
[TBL] [Abstract][Full Text] [Related]
31. [Successful treatment of small cell lung cancer with secondary immune thrombocytopenic purpura].
Terashita S; Hirano K; Hirai T; Narabayashi T; Hara Y; Endo K; Hirabayashi M
Nihon Kokyuki Gakkai Zasshi; 2009 Nov; 47(11):1036-40. PubMed ID: 19994601
[TBL] [Abstract][Full Text] [Related]
32. Autologous bone marrow and peripheral blood progenitor cell transplants in small cell lung cancer.
Lazarus HM; Elias AD
Bone Marrow Transplant; 1996 Jan; 17(1):1-3. PubMed ID: 8673040
[No Abstract] [Full Text] [Related]
33. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
Molina A; Krishnan AY; Nademanee A; Zabner R; Sniecinski I; Zaia J; Forman SJ
Cancer; 2000 Aug; 89(3):680-9. PubMed ID: 10931469
[TBL] [Abstract][Full Text] [Related]
34. [Kinetics of hematopoiesis after high-dose chemotherapy and autologous peripheral stem cell transplantation].
Mayer J; Korístek Z; Pospísil Z; Vásová I; Adam Z; Hájek R; Krejcí M; Král Z; Navrátil M; Vorlícek J; Bourková L; Matýsková M; Adler J; Vinklárková J; Klabusay M; Koutná I; Hoffová V; Schmitzová D; Janovská E
Cas Lek Cesk; 1999 Mar; 138(6):170-7. PubMed ID: 10510531
[TBL] [Abstract][Full Text] [Related]
35. Multiple cycles of PBPC-supported high-dose carboplatin and paclitaxel following mobilization with epirubicin and cisplatin are feasible but ineffective in treating patients with advanced non-small cell lung cancer.
De Giorgi U; Rosti G; Ciucci G; Kopf B; Minzi C; Argnani M; Marangolo M
Bone Marrow Transplant; 2007 Oct; 40(8):735-9. PubMed ID: 17700603
[TBL] [Abstract][Full Text] [Related]
36. Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease.
Musso M; Porretto F; Crescimanno A; Bondi F; Polizzi V; Scalone R
Am J Hematol; 2001 Feb; 66(2):75-9. PubMed ID: 11421302
[TBL] [Abstract][Full Text] [Related]
37. Preoperative high-dose chemotherapy with peripheral blood stem cell support as a primary management of locally advanced breast cancer.
Wang X; Tang J; Wu J; Feng J; Pang L; Dai A; Zheng X
Bone Marrow Transplant; 2001 Feb; 27(3):345-6. PubMed ID: 11277186
[TBL] [Abstract][Full Text] [Related]
38. [Intensive therapy with paclitaxel (Taxol) and cyclophosphamide followed by administration of G-CSF as a mobilization regimen in patients with breast carcinoma and indications for autologous hematopoietic cell transplantation].
Trnĕný M; Apltauerová M; Mares P; Gasová Z; Hrubá A; Jelínek J; Marinov I; Klener P
Sb Lek; 2002; 103(3):349-57. PubMed ID: 12688179
[TBL] [Abstract][Full Text] [Related]
39. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW
Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105
[TBL] [Abstract][Full Text] [Related]
40. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation support in a patient with breast cancer metastasis to bone marrow: immunocytochemical monitoring of cancer-cell contamination].
Uno H; Fujita M; Hino N; Nakagawa H; Miyagawa H; Aoki J; Taniyama K; Sasaki N
Rinsho Ketsueki; 1999 Jul; 40(7):556-62. PubMed ID: 10483138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]